Statins: Is it safe and effective to use generic “equivalents”?
Jackevicius CA, Tu JV, Krumholz HM. Can J Cardiol. 2012; 29(4):408-10. Epub 2012 Oct 16.
Publications
Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation
Avgil-Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L. JAMA. 2012; 307(18):1952-58.
Use of fibrates in the United States and Canada
Jackevicius CA, Tu JV, Ross JS, Ko DT, Carreon D, Krumholz HM. JAMA. 2011; 305(12):1217-24. Epub 2011 Mar 23.
National trends in cardiovascular care and outcomes
Tu JV, Jackevicius CA, Lee DS, Donovan LR; Canadian Cardiovascular Outcomes Research Team. Healthc Q. 2010;13(1):22-5.
Long-term trends in use of and expenditures for cardiovascular medications in Canada
Jackevicius CA, Cox JL, Carreon D, Tu JV, Rinfret S, So D, Johansen H, Kalavrouziotis D, Demers V, Humphries K, Pilote L; Canadian Cardiovascular Outcomes Research Team. CMAJ. 2009; 181(1-2):E19-28.
Cardiovascular outcomes after a change in prescription policy for clopidogrel
Jackevicius CA, Tu JV, Demers V, Melo M, Cox J, Rinfret S, Kalavrouziotis D, Johansen H, Behlouli H, Newman A, Pilote L. N Engl J Med. 2008; 359(17):1802-10.
Use of ezetimibe in the United States and Canada
Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. N Engl J Med. 2008; 358(17):1819-28. Epub 2008 Mar 30.
Prevalence, predictors and outcomes of primary nonadherence after acute myocardial infarction
Jackevicius CA, Li P, Tu JV. Circulation. 2008; 117(8):1028-36.
Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients
Jackevicius CA, Paterson JM, Naglie G. Pharmacoepidemiol Drug Saf. 2007; 16(2):207-15.
Acute treatment of myocardial infarction in Canada 1999-2002
Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2005; 21(2):145-52.